WO2005019152A2 - Process for preparing 3-aryl-2-hydroxy propanoic acid derivatives without resolution - Google Patents
Process for preparing 3-aryl-2-hydroxy propanoic acid derivatives without resolution Download PDFInfo
- Publication number
- WO2005019152A2 WO2005019152A2 PCT/IN2004/000156 IN2004000156W WO2005019152A2 WO 2005019152 A2 WO2005019152 A2 WO 2005019152A2 IN 2004000156 W IN2004000156 W IN 2004000156W WO 2005019152 A2 WO2005019152 A2 WO 2005019152A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- compound
- alkyl
- agent
- base
- Prior art date
Links
- 0 *O[C@@](C=C1C=CC(O)=CC1)C(O*)=O Chemical compound *O[C@@](C=C1C=CC(O)=CC1)C(O*)=O 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N N[C@@H](Cc(cc1)ccc1O)C(O)=O Chemical compound N[C@@H](Cc(cc1)ccc1O)C(O)=O OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- OUYCCCASQSFEME-MRVPVSSYSA-N N[C@H](Cc(cc1)ccc1O)C(O)=O Chemical compound N[C@H](Cc(cc1)ccc1O)C(O)=O OUYCCCASQSFEME-MRVPVSSYSA-N 0.000 description 2
- KAFHLONDOVSENM-HNNXBMFYSA-N N[C@@H](Cc(cc1)ccc1OCc1ccccc1)C(O)=O Chemical compound N[C@@H](Cc(cc1)ccc1OCc1ccccc1)C(O)=O KAFHLONDOVSENM-HNNXBMFYSA-N 0.000 description 1
- KAFHLONDOVSENM-OAHLLOKOSA-N N[C@H](Cc(cc1)ccc1OCc1ccccc1)C(O)=O Chemical compound N[C@H](Cc(cc1)ccc1OCc1ccccc1)C(O)=O KAFHLONDOVSENM-OAHLLOKOSA-N 0.000 description 1
- JVGVDSSUAVXRDY-QMMMGPOBSA-N O[C@@H](Cc(cc1)ccc1O)C(O)=O Chemical compound O[C@@H](Cc(cc1)ccc1O)C(O)=O JVGVDSSUAVXRDY-QMMMGPOBSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/297—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/10—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with ester groups or with a carbon-halogen bond
- C07C67/11—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with ester groups or with a carbon-halogen bond being mineral ester groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/377—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Definitions
- the present invention relates to a process for the preparation of S (-) & R (+) isomers of 3- aryl-2-alkoxy propanoic acid derivatives of the structural formula (la) & (lb) respectively,
- S (-)-3-aryl-2-alkoxy propanoic acid derivatives are essential intermediates for the preparation of a number of promising drugs. These compounds also have been considered useful for the treatment of eating disorders. They are also used as sweetening agents, in photosensitive materials and also in liquid crystals.
- WO 0026200 Such processes are described in WO 0026200, WO 0140159, WO 0224625, WO 9962871 and WO 0063189.
- the processes described in WO 0026200 (Rao et. al.) uses benzyl bromide for benzylation, which is highly lachrymatory. Again, in the processes described, the debenzylation of the final intermediate was done by using Pd/C under pressure. Such a process is costly and not very efficient at a large scale.
- WO 0224625 describes a process for preparing chirally pure S (-) alkyl-2-alkoxy-3-(4-benzyloxyphenyl) propanoate. However, the process for obtaining the chirally pure product involves the following steps:
- R 3 H .
- the present invention relates to a process for . the preparation of S (-) & R (+) 3-aryl ⁇ 2-alkoxy propanoic acid derivatives of the structural formula (la) & (lb) respectively, which not only overcomes the draw backs of prior art, but also provides an improved process which possess several advantages like operational simplicity, cost effectiveness and easily implementable on a large scale.
- the present invention relates to an improved process of preparation of S (-) & R (+) 3-aryl-2- alkoxy propanoic acid derivatives of the structural formula (la) & (lb) respectively, of high chemical and chiral purity.
- the main objective of the present invention is to provide an improved process for the preparation of S (-) & R (+) 3-aryl-2-alkoxy propanoic acid derivatives of formula (la) &
- Another objective of is to provide a cost-effective, safe and efficient process for obtaining chirally pure compounds of formula (la) & (lb) respectively.
- a further objective of the present invention is to provide a process for the large scale production of compound of formula (la) & (lb) in a chirally pure form.
- the present invention describes an improved process for the preparation of compound of the general formula (la) and (lb).
- R 1 represent H or (Ci-C ⁇ ) alkyl group such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl and the like.
- R 2 represents (C C ⁇ ) alkyl group such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t- butyl and the like.
- R 3 represents H, protecting groups such as benzyl, substituted benzyl, (C ⁇ -C- alkyl and like.
- Step 1 Selective O-alkylation or O-aralkylation of L-Tyrosine of formula (2a) using a base, a chelating agent, an alkyl or aralkyl halide in the presence of solvents to obtain the compound of formula (3a) (according to the general method described in "The practice of peptide synthesis", Bodanszky et. al., pp 50)
- the selective O-alkylation or O-aralkylation of compound of formula (2a) can be carried out by reacting a base such as NaOH, KOH, K 2 CO 3 and the like, a chelating agent such as CuSO 4 , Cu (OAc) 2 and the like, and an alkyl or aralkyl halide in the presence of solvents such as aq. methanol, ethanol, DMF and the like or their combination thereof, at 25 °C-65 °C.
- the bases may be present in 2-2.5 equivalents, the chelating agent in 0.5-0.7 equivalents, alkyl or aralkyl halide in 1-1.5 eq. and the solvent may be present in 4-20 times to the weight of L- tyrosine.
- the base used is KOH (2 to 2.2 eq.)
- the chelating agent is CuSO 4 (0.5 to 0.65 eq.)
- Benzyl chloride is the aralkylating agent and the solvent used is aq. DMF at 50 °C-60 °C, to afford the copper complex of O-benzyl-L-tyrosine.
- aqueous methanol WO 0026200 & WO 0224625
- the rate of reaction is enhanced resulting in higher yield and better purity.
- the volume of solvent required is reduced substantially (from ⁇ 20 times of the starting compound in case of MeOH to 4 times the starting compound in case of DMF).
- Step 2 Diazotisation of the compound of the formula (3a) using a diazotising agent, in suitable solvents in acidic media to obtain the compound of formula (4a).
- Diazotisation of the compound of formula (3a) is carried out with sodium nitrite in 2-5 equivalents, preferably 3-4 equivalents and strong acids such as sulfuric acid, orthophosphoric acid, cone. HC1 in 2-8 equivalents, KHSO 4 , preferably sulfuric acid in 3-5 equivalents at 0 °C to 25 °C. Solvents such as dioxane, acetone, methyl ethyl ketone and the like or their mixtures, preferably dioxane, may be used. [Tetrahedron Lett., 25, 2287- 2290(1971) & US 5,747,448 which are incorporated herein as reference]. The hydroxy acid (4a) was obtained in high chemical & chiral purity (e.e. > 98 %) with retention of configuration. Step 3: Dialkylation of the compound of formula (4a) using an excess of alkylating agent and excess base, in presence of suitable solvent to obtain optically pure compound of formula
- compound of formula (4a) may be selectively esterif ⁇ ed to obtain compound of formula (5a), which is subsequently O-alkylated to obtain compound of formula (la) (Scheme 2)
- Dialkylation of the compound of formula (4a) to get the dialkylated compound of formula (la) with high chemical and chiral purity was carried out by suitably modifying the process reported by Robert A.W. Johnstone et.al. (Tetrahedron, 35, 2169-2173, (1979)), which describes the alkylation of aliphatic alcohols and acids with alkylating agents at ambient temperature i.e.18-20 °C using an excess of potassium hydroxide as a base and DMSO as a solvent.
- dialkylation of the compound of formula (4a) was carried out using an excess of base w.r.to the starting compound, with a suitable alkylating agent in presence of a solvent to obtain the compound of formula (la).
- Suitable alkylating agents may be alkyl sulfates such as diethyl sulfate, dimethyl sulfate and the like; alkyl halides may be methyl iodide, ethyl iodide, ethyl bromide, propyl bromide, isopropyl bromide and the like.
- the solvent used is DMSO.
- the base may be present in 2 to 7 equivalents, preferably in 5 to 7 equivalents, the alkylating agent is present in equal moles w.r.to the base, and the solvent volume may be 4-10 times w.r.to the weight of the intermediate of formula (4a).
- Suitable base may be selected from NaH, KOH, t-BuOK and the like.
- the compound (4a) is obtained with high chemical (> 98 %) and chiral (e. e > 97 %) purity.
- Prior art for this conversion reports the formation of ⁇ 20 % byproduct and upto 4 % racemization. (Deussen et. al.
- the esterification may be carried out in the presence of a suitable base selected from Na 2 CO 3 , K 2 CO 3 , KOH, NaOMe, NaOEt and the like or mixture thereof in the presence of corresponding alkylating agents such as methyl iodide, ethyl iodide, dimethyl sulfate, diethyl sulfate and the like in solvents selected from DMF, DMSO and the like or mixtures thereof.
- the alkylation of compound of formula (5a) to obtain compound of formula (la) may be carried out using an excess of base w.r.to the starting compound, with a suitable alkylating agent in the presence of a solvent to obtain compound of formula (la).
- Suitable alkylating agents may be alkyl sulfates such as diethyl sulfate, dimethyl sulfate and the like; alkyl halides selected from methyl iodide, ethyl iodide, ethyl bromide, propyl bromide, isopropyl bromide and the like.
- the solvent used is DMSO.
- the base may be present in 2 to 7 equivalents, preferably in 5 to 7 equivalents, the alkylating agent is present in equal moles w.r.to the base, and the solvent volume may be 4-10 times w.r.to the weight of the intermediate of formula (5a).
- Suitable base may be selected from NaH, KOH, t-BuOK and the like.
- the crude product of formula (la) was purified by removal of excess alkyl halide or alkyl sulfate to obtain chemically pure and high chirally pure (e.e > 97%) compound of formula (la) without resolution. Removal of excess alkyl halide from the product can be done by vacuum distillation or by reacting with trialkyl amines like triethyl amine.
- alkyl sulfate the excess alkyl sulfate, may be removed by treating with an organic base such as, trialkyl amines preferably with triethylamine and diisopropyl ethylamine (1-2 equivalents to alkyl sulfate) in suitable alcohol at a temp, ranging from 25-30 °C to reflux temperature of the solvent.
- an organic base such as, trialkyl amines preferably with triethylamine and diisopropyl ethylamine (1-2 equivalents to alkyl sulfate) in suitable alcohol at a temp, ranging from 25-30 °C to reflux temperature of the solvent.
- the deprotection may be carried out in the presence of an ester group.
- Suitable acids for carrying out such deprotection may be Lewis acids such as AICI3, BF 3 etherate, BF 3 acetate and the like, preferably BF 3 etherate in 1.5 to 6 equivalents.
- Suitable nucleophiles may be alkylthiols like ethanethiol, propanethiol, ethanedithiol, and the like, or -suitable alkyl aryl sulphides or dialkyl sulfides, preferably alkyl aryl sulfides more preferably thioanisole, in 1.5-7 equivalents. Solvents, if required may be selected from CH 2 C1 2 , CHC1 3 and like or mixtures thereof. The product contains less than or equal to 0.3 % of the rearranged product S (-) alkyl-2-alkoxy-3-(3-benzyl-4-hydroxyphenyl) propanoate. Suitable proportion of the Lewis acid and nucleophile may be used to minimize or remove the re- arranged side product.
- suitable solvents include ethyl acetate, THF, dioxane, glacial acetic acid, aqueous or non aqueous alcohols such as methanol, ethanol, isopropanol and the like or their mixtures.
- ethyl acetate in 5-10 volumes is used.
- Suitable hydrogen donor reagent may be ammonium formate, cyclohexene, 1,4-cyclohexadiene and the like, preferably, ammonium formate in 3-6 equivalent.
- the product often contains less than or equal to 0.3 % of the rearranged product S (-) alkyl-2-alkoxy-3-(3-benzyl-4-hydroxyphenyl) propanoate.
- One skilled in the art may appreciate that minor differences in the temperature and reaction times may produce the same result and the other temperatures and time may produce the same result under other condition.
- the present invention provides a novel process for the preparation of chemically & chirally pure S (-) 3-aryl-2-alkoxy propanoic acid derivatives of formula (la). 2.
- the present invention provides a manufacturing process for the preparation of chemically and optically pure compounds of formula (la), without using resolution at any stage.
- the invention also describes a process of converting compound of formula (2a) to compound of formula (3a) using DMF as the solvent. This has the benefit of enhancing the reactivity; thereby the reaction goes to completion and the product is obtained in high yield (55 %) with high chemical and chiral purity.
- Another advantage is the reduction of reaction time (4-6 hours) during conversion of compound of formula (4a) to (la) compared to that reported in some of the literature ( 24 - 36 hours, WO 0224625).
- This invention provides a method to obtain compound of formula (3a) in high assay and purity.
- This invention provides a method to remove excess dialkyl sulfate in the presence of sensitive ester functional group during the conversion of compound of formula (4a) to (la) (R 3 ⁇ H).
- the present invention provides an industrial process for the manufacture of compound of formula (la) which is practical, safe and cost effective.
- Scheme 3 (i) Selective O-alkylation or O-aralkylation of D-tyrosine of formula (2b) by reacting a) a base and a chelating agent to obtain the copper complex; b) reacting the chelated product with an alkylating agent in the presence of solvents to obtain the compound of formula (3b), where R 3 represents suitable protective groups, by a process similar to that disclosed for the preparation of compound of formula (3a), scheme 1;
- the compound of formula (lb), where all symbols are as defined earlier is obtained by the process comprising (i) converting the compound of formula (4b) to compound of formula (5b), by a process similar to that disclosed for the preparation of compound of formula (5 a), scheme 2;
- the wet cake of O-benzyl-L-tyrosine copper complex (18.2 kg) was stirred with methanol in a 50 L glass assembly at reflux temperature. The solids were filtered hot through filter cloth using nutch filter, drained well and washed with methanol. It was dried in an oven at 65 °C- 70 °C.
- the copper complex of O-benzyl-L-tyrosine weighed about 4.6 kg.
- the Cu complex of O-benzyl-L-tyrosine was added into water in a 30 lit S.S. tank. It was stirred at ca.26-28 °C. To this slurry 35 % cone. HC1 (3.32 L) was added with stirring, and the solids obtained were filtered and drained well followed by washing with water and 10 % ammonia solution. The wet cake was centrifuged and again washed with water. The solids were dried in an oven at 65 °C-70 °C. The off white O-benzyl-L-tyrosine was obtained in 56 % yield (2.63 kg) with 95.8 % assay by HPLC and 100 % e.e.
- the mixture was cooled to ca 26-28 °C, stirred, and resulting solids were collected by filtration, washed with water and drained well under vacuum.
- the wet cake of O-benzyl-L-tyrosine copper complex (25.6 kg) was stirred with methanol in a 100 L glass assembly at reflux temperature. The solids were filtered hot through filter cloth using nutch filter, drained well and washed with methanol. It was dried in an oven at 65 °C- 70 °C.
- the copper complex of O-benzyl-L-tyrosine weighed about 8.2 kg.
- the Cu complex of O-benzyl-L-tyrosine was added into water in a 50 lit S. S.
- Example 8 S (-) 2-hydroxy-3- (4-benzyloxyphenyl) propanoic acid To a 20 L round bottom three necked flask, 1,4 dioxane (6.25 L) was added followed by O- benzyl-L-tyrosine (500g, 1.84 mol). To this suspension dilute aqueous sulfuric acid solution (540 g, 5.53 mol, in 2.5 L water) was added at RT. It was cooled to 0 °C-2 °C in an ice salt bath. At 0 °C, aqueous sodium nitrite solution (636 g, 9.22 mol) was added. After the addition, it was stirred for extended period of time ( ⁇ upto 24 hours) below 30 °C.
- the layers were separated, the organic layer was collected and aqueous layer again extracted with toluene. The combined organic layers were washed with water and brine. The organic layer after drying over anhydrous sodium sulfate and distilling under reduced pressure gave reddish brown liquid product.
- the liquid product weighs 1 kg which contains 38.39 % diethyl sulfate (GC). The chemical purity of the product was 98.0 % by HPLC.
- the crude liquid product was taken in a three-necked round bottom flask. To the product ethanol (2.2 L) and triethylamine (440 ml) were added. It was heated to reflux temperature and stirred. The excess ethanol was distilled out at reduced pressure.
- the layers were separated, the organic layer was collected and aqueous layer again extracted with toluene. The combined organic layers were washed with water and brine. The organic layer after drying over anhydrous sodium sulfate and distilling under reduced pressure gave reddish brown liquid product.
- the liquid product weighs 2.628 kg which contains 48.3 % diethyl sulfate by GC. The chemical purity of the product was 97.9 % by HPLC.
- the crude liquid product was taken in a three necked round bottom flask. To the product ethanol (10 L) and triethylamine (1.4 1) were added. It was heated to reflux temperature and stirred. The excess ethanol was distilled out at reduced pressure.
- the organic layer after drying over anhydrous sodium sulfate was distilled out at reduced pressure to obtain title compound in a liquid form.
- the liquid product weighs 33.2 g which contains 68 % diethyl sulfate by GC.
- the chemical purity of the product is 93.0 % by HPLC.
- the crude liquid product was taken in a three necked round bottom flask. To the product ethanol (150 mL) and triethylamine (23.0 ml) were added. It was heated to reflux temperature with stirring. The excess ethanol was distilled out at reduced pressure. The liquid residue was dumped into ice-cold water and extracted with ethyl acetate. The organic layer was washed with brine.
- the crude liquid product was stirred with diisopropyl ether at ca. 25-30 °C to extract the desired product.
- the d ⁇ soisopropyl ether was removed to obtain the crude liquid product, which was stirred with n-heptane at ca. 25-30 °C to obtain the solid product in 70 % yield
- the mixture was cooled to ca. 26-28 °C, stirred and resulting solids were collected by filtration, washed with water and drained well under vacuum.
- the wet cake of O-benzyl-D-tyrosine copper complex (200 g) was stirred with methanol at reflux temperature. The solids were filtered and washed with methanol. It was dried in an oven at 65 °C-70 °C. The copper complex of O-benzyl-D-tyrosine weighed about 150 g.
- Example 23 (+)-ethyl-2-ethoxy-3 -(4-benzyloxyphenyl) propanoate In a dry, three necked round bottom flask dimethyl sulfoxide (DMSO, 96 mL) was added followed by potassium hydroxide pellets (39 g, 0.59 mol).
- DMSO dimethyl sulfoxide
Abstract
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006508489A JP2006527186A (en) | 2003-06-06 | 2004-06-04 | Method for preparing 3-aryl-2-alkoxypropanoic acid without resolution |
AU2004266204A AU2004266204A1 (en) | 2003-06-06 | 2004-06-04 | Process for preparing 3-aryl-2-hydroxy propanoic acid derivatives without resolution |
AP2005003462A AP2005003462A0 (en) | 2003-06-06 | 2004-06-04 | Process for preparing 3-aryl-2-hydroxy propanoic acid derivatives without resolution. |
MXPA05013216A MXPA05013216A (en) | 2003-06-06 | 2004-06-04 | Process for preparing 3-aryl-2-hydroxy propanoic acid derivatives without resolution. |
CA002527953A CA2527953A1 (en) | 2003-06-06 | 2004-06-04 | Process for preparing 3-aryl-2-hydroxy propanoic acid derivatives without resolution |
EP04785914A EP1636164A2 (en) | 2003-06-06 | 2004-06-04 | Process for preparing 3-aryl-2-hydroxy propanoic acid derivatives without resolution |
BRPI0411409-4A BRPI0411409A (en) | 2003-06-06 | 2004-06-04 | process for the preparation of propanoic acid derivatives and process for the preparation of a compound having the formula (1a) |
IL172260A IL172260A0 (en) | 2003-06-06 | 2005-11-29 | Process for preparing 3-aryl-2-hydroxy propanoic acid derivatives without resolution |
GBGB0526499.9A GB0526499D0 (en) | 2003-06-06 | 2005-12-28 | Process for preparing 3-aryl-2-hydroxy propanoic acid derivatives without resolution |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN586MU2003 | 2003-06-06 | ||
IN586/MUM/2003 | 2003-06-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005019152A2 true WO2005019152A2 (en) | 2005-03-03 |
WO2005019152A3 WO2005019152A3 (en) | 2005-08-11 |
Family
ID=34204135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2004/000156 WO2005019152A2 (en) | 2003-06-06 | 2004-06-04 | Process for preparing 3-aryl-2-hydroxy propanoic acid derivatives without resolution |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1636164A2 (en) |
JP (1) | JP2006527186A (en) |
KR (1) | KR20060015640A (en) |
AP (1) | AP2005003462A0 (en) |
AU (1) | AU2004266204A1 (en) |
BR (1) | BRPI0411409A (en) |
CA (1) | CA2527953A1 (en) |
GB (1) | GB0526499D0 (en) |
IL (1) | IL172260A0 (en) |
MX (1) | MXPA05013216A (en) |
WO (1) | WO2005019152A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006016517A1 (en) * | 2004-08-13 | 2006-02-16 | Kaneka Corporation | Process for producing optically active 2-substituent-oxy-3-(4-substituent-oxyphenyl)propionic acid derivative |
WO2014181362A1 (en) | 2013-05-09 | 2014-11-13 | Council Of Scientific & Industrial Research | A process for the preparation of 3-aryl-2-hydroxy propanoic acid compounds |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6258850B1 (en) * | 1998-06-04 | 2001-07-10 | Astrazeneca Ab | 3-aryl-2-hydroxypropionic acid derivative (I) |
WO2002024625A2 (en) * | 2000-09-22 | 2002-03-28 | Dr. Reddy's Research Foundation | Process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives |
WO2003027084A1 (en) * | 2001-09-25 | 2003-04-03 | Dr. Reddy's Laboratories Ltd. | Improved process for the preparation of optically active phenoxazine derivatives as antidiabetic agents |
-
2004
- 2004-06-04 KR KR1020057023385A patent/KR20060015640A/en not_active Application Discontinuation
- 2004-06-04 AP AP2005003462A patent/AP2005003462A0/en unknown
- 2004-06-04 AU AU2004266204A patent/AU2004266204A1/en not_active Abandoned
- 2004-06-04 JP JP2006508489A patent/JP2006527186A/en active Pending
- 2004-06-04 BR BRPI0411409-4A patent/BRPI0411409A/en not_active Application Discontinuation
- 2004-06-04 CA CA002527953A patent/CA2527953A1/en not_active Abandoned
- 2004-06-04 MX MXPA05013216A patent/MXPA05013216A/en unknown
- 2004-06-04 EP EP04785914A patent/EP1636164A2/en not_active Withdrawn
- 2004-06-04 WO PCT/IN2004/000156 patent/WO2005019152A2/en not_active Application Discontinuation
-
2005
- 2005-11-29 IL IL172260A patent/IL172260A0/en unknown
- 2005-12-28 GB GBGB0526499.9A patent/GB0526499D0/en not_active Ceased
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6258850B1 (en) * | 1998-06-04 | 2001-07-10 | Astrazeneca Ab | 3-aryl-2-hydroxypropionic acid derivative (I) |
WO2002024625A2 (en) * | 2000-09-22 | 2002-03-28 | Dr. Reddy's Research Foundation | Process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives |
WO2003027084A1 (en) * | 2001-09-25 | 2003-04-03 | Dr. Reddy's Laboratories Ltd. | Improved process for the preparation of optically active phenoxazine derivatives as antidiabetic agents |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006016517A1 (en) * | 2004-08-13 | 2006-02-16 | Kaneka Corporation | Process for producing optically active 2-substituent-oxy-3-(4-substituent-oxyphenyl)propionic acid derivative |
WO2014181362A1 (en) | 2013-05-09 | 2014-11-13 | Council Of Scientific & Industrial Research | A process for the preparation of 3-aryl-2-hydroxy propanoic acid compounds |
US9550719B2 (en) | 2013-05-09 | 2017-01-24 | Council Of Scientific And Industrial Research | Process for the preparation of 3-aryl-2-hydroxy propanoic acid compounds |
Also Published As
Publication number | Publication date |
---|---|
AU2004266204A1 (en) | 2005-03-03 |
JP2006527186A (en) | 2006-11-30 |
BRPI0411409A (en) | 2006-07-25 |
IL172260A0 (en) | 2009-02-11 |
AP2005003462A0 (en) | 2005-12-31 |
KR20060015640A (en) | 2006-02-17 |
EP1636164A2 (en) | 2006-03-22 |
WO2005019152A3 (en) | 2005-08-11 |
GB0526499D0 (en) | 2006-02-08 |
CA2527953A1 (en) | 2005-03-03 |
MXPA05013216A (en) | 2006-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1451143B1 (en) | Methods for preparing o-desmethylvenlafaxine | |
KR101099995B1 (en) | New process for the synthesis of strontium ranelate and its hydrates | |
JPH05213838A (en) | Preparation of fluoxetine | |
US20020072635A1 (en) | Production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols | |
WO2005019152A2 (en) | Process for preparing 3-aryl-2-hydroxy propanoic acid derivatives without resolution | |
IE54216B1 (en) | Stereospecific synthesis of 5-phenyl-2s-pentanol | |
US20070155994A1 (en) | Optical resolver and method of optically resolving alcohol with the same | |
US4231962A (en) | 3-Phenoxybenzylideneamines and 3-benzylbenzylideneamines | |
SK29099A3 (en) | Process for the preparation of fluoxetine | |
JPH05286889A (en) | Production of arylacetic acid and its alkali metal salt | |
US6867307B2 (en) | Intermediates for use in the preparation of vitamin E | |
US5696283A (en) | Preparation of methyl isoproylideneaminooxyacetoxyacetate | |
CN115286504B (en) | Method for synthesizing (R) -2- (2- (tert-butoxy) -2-oxyethyl) pentanoic acid | |
EP0483674B1 (en) | A process for producing an aliphatic amide and salts thereof | |
KR940011899B1 (en) | Process for the synthesis of the n-methyl-3,4-dimethoxyphenyl ethyl amine | |
KR100803746B1 (en) | New synthetic method of raloxifene | |
JP4039026B2 (en) | Method for producing 3-amino-2-thiophenecarboxylic acid ester | |
FR2614619A1 (en) | Process for the preparation of N-(2-chlorobenzyl)-2-(2-thienyl)ethylamine | |
US6806395B2 (en) | Process for preparation of 3,5-bisalkylphenols | |
US6291696B2 (en) | Preparation of tris (trimethylsilyl) silylethyl esters | |
JP3911302B2 (en) | Process for producing optically active 2-methylpiperazine | |
JP4294130B2 (en) | Method for producing α, β-unsaturated ketone compound | |
EP0321349A1 (en) | Process for the preparation of N-(2-chloro-benzyl)(2-thienyl)-2-ethyl amine | |
JP3922607B2 (en) | Process for producing p- or m-hydroxyalkylbenzene and intermediates thereof | |
JP2589564B2 (en) | Preparation of styrene derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 172260 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200509694 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2527953 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: AP/P/2005/003462 Country of ref document: AP Ref document number: 2006508489 Country of ref document: JP Ref document number: 12005502187 Country of ref document: PH Ref document number: 2004266204 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2005/013216 Country of ref document: MX Ref document number: 1020057023385 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 05127536 Country of ref document: CO |
|
ENP | Entry into the national phase |
Ref document number: 2004266204 Country of ref document: AU Date of ref document: 20040604 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 544380 Country of ref document: NZ |
|
WWP | Wipo information: published in national office |
Ref document number: 2004266204 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: GB0526499.9 Country of ref document: GB |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004785914 Country of ref document: EP Ref document number: 200501923 Country of ref document: EA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2004785914 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057023385 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2004785914 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0411409 Country of ref document: BR |